PE20160014A1 - Formulacion de una composicion sanguinea rica en plaquetas y/o factores de crecimiento, con proteinas gelificadas, y metodo de preparacion de la misma - Google Patents
Formulacion de una composicion sanguinea rica en plaquetas y/o factores de crecimiento, con proteinas gelificadas, y metodo de preparacion de la mismaInfo
- Publication number
- PE20160014A1 PE20160014A1 PE2015002551A PE2015002551A PE20160014A1 PE 20160014 A1 PE20160014 A1 PE 20160014A1 PE 2015002551 A PE2015002551 A PE 2015002551A PE 2015002551 A PE2015002551 A PE 2015002551A PE 20160014 A1 PE20160014 A1 PE 20160014A1
- Authority
- PE
- Peru
- Prior art keywords
- formulation
- platelets
- proteins
- blood composition
- growth factors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3616—Blood, e.g. platelet-rich plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Formulacion que comprende o se deriva de una composicion sanguinea inicial rica en plaquetas y/o factores de crecimiento y proteinas provenientes de la propia composicion sanguinea inicial, donde dichas proteinas se encuentran en estado gelificado. Se reivindica asimismo un metodo de preparacion de dicha formulacion, que comprende los pasos de calentar y posteriormente enfriar la composicion sanguinea inicial a unas determinadas temperaturas y tiempos. Entre otras ventajas, la formulacion segun la invencion es biocompatible y biodegradable, presenta las propiedades biologicas o medicas deseables proporcionadas por la presencia de plaquetas o factores de crecimiento, y ademas presenta una elevada estabilidad dimensional a lo largo del tiempo
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201300718A ES2527967B1 (es) | 2013-08-01 | 2013-08-01 | Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas y método de preparación de la misma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20160014A1 true PE20160014A1 (es) | 2016-01-29 |
Family
ID=51422102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2015002551A PE20160014A1 (es) | 2013-08-01 | 2014-07-31 | Formulacion de una composicion sanguinea rica en plaquetas y/o factores de crecimiento, con proteinas gelificadas, y metodo de preparacion de la misma |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9861684B2 (es) |
| EP (1) | EP3028710B1 (es) |
| JP (1) | JP6466443B2 (es) |
| KR (1) | KR20160036557A (es) |
| CN (1) | CN105431155B (es) |
| AR (1) | AR097176A1 (es) |
| BR (1) | BR112015031733A2 (es) |
| CA (1) | CA2919314C (es) |
| CL (1) | CL2015003579A1 (es) |
| ES (2) | ES2527967B1 (es) |
| MX (1) | MX2016001238A (es) |
| PE (1) | PE20160014A1 (es) |
| PL (1) | PL3028710T3 (es) |
| PT (1) | PT3028710T (es) |
| RU (1) | RU2697249C2 (es) |
| TW (1) | TWI684454B (es) |
| WO (1) | WO2015015037A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6999927B2 (ja) * | 2017-11-13 | 2022-01-19 | 株式会社細胞応用技術研究所 | 多血小板血漿を製造する方法 |
| EP3747475A4 (en) | 2018-01-30 | 2021-06-02 | FUJIFILM Corporation | FIBRIN COMPOSITION, BASIC MATERIAL FOR REGENERATIVE MEDICINE, METHOD FOR MANUFACTURING FIBRIN COMPOSITION AND KIT |
| ES2778798B2 (es) * | 2019-02-11 | 2021-10-13 | Biotechnology Inst I Mas D Sl | Formulacion o adhesivo tisular obtenida de una composicion sanguinea que contiene plaquetas, y metodo de preparacion de dicha formulacion |
| ES2782723B2 (es) * | 2019-03-13 | 2021-05-18 | Active Bioregeneration Tech Sl | Procedimiento para obtencion y conservacion de factores de crecimiento de alta pureza y sus usos |
| RU2755347C1 (ru) * | 2020-12-11 | 2021-09-15 | Денис Григорьевич Кайгородов | Композиция для коррекции возрастных изменений кожи и способ ее получения |
| CN115531592A (zh) * | 2022-10-27 | 2022-12-30 | 李升红 | 一种实现皮肤高效修复的皮肤敷料及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR022333A1 (es) * | 1999-01-26 | 2002-09-04 | Anitua Aldecoa Eduardo | Regenerador de tejido oseo |
| US7015198B1 (en) * | 1999-05-11 | 2006-03-21 | Orentreich Foundation For The Advancement Of Science, Inc. | Materials for soft tissue augmentation and methods of making and using same |
| US8389687B2 (en) * | 2000-10-23 | 2013-03-05 | Shanbrom Technologies, Llc | Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors |
| ES2221770B2 (es) | 2002-04-19 | 2006-07-16 | Eduardo Anitua Aldecoa | Metodo de preparacion de un compuesto para la regeneracion de tejidos. |
| AU2007275579B2 (en) * | 2006-07-21 | 2012-05-03 | Genera Istrazivanja D.O.O. | Whole blood-derived coagulum device for treating bone defects |
| ES2333498B1 (es) | 2007-08-02 | 2011-01-10 | Biotechnology Institute, I Mas D, S.L. | Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. |
| EP2470229B1 (en) * | 2009-06-11 | 2017-08-23 | Universitat Autònoma De Barcelona | Use of gelled prp (platelet gel) for volumetric breast reconstruction |
| US9901659B2 (en) * | 2010-05-27 | 2018-02-27 | University of Pittsburgh—of the Commonwealth System of Higher Education | Wet-electrospun biodegradable scaffold and uses therefor |
| ES2369945B1 (es) * | 2011-07-29 | 2012-10-15 | Eduardo Anitua Aldecoa | Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento. |
-
2013
- 2013-08-01 ES ES201300718A patent/ES2527967B1/es active Active
-
2014
- 2014-07-29 TW TW103125833A patent/TWI684454B/zh not_active IP Right Cessation
- 2014-07-31 EP EP14756084.1A patent/EP3028710B1/en active Active
- 2014-07-31 JP JP2016530556A patent/JP6466443B2/ja active Active
- 2014-07-31 WO PCT/ES2014/070623 patent/WO2015015037A1/es active Application Filing
- 2014-07-31 BR BR112015031733A patent/BR112015031733A2/pt active Search and Examination
- 2014-07-31 RU RU2016102768A patent/RU2697249C2/ru active
- 2014-07-31 CN CN201480042878.XA patent/CN105431155B/zh not_active Expired - Fee Related
- 2014-07-31 ES ES14756084T patent/ES2755172T3/es active Active
- 2014-07-31 CA CA2919314A patent/CA2919314C/en active Active
- 2014-07-31 MX MX2016001238A patent/MX2016001238A/es active IP Right Grant
- 2014-07-31 AR ARP140102877A patent/AR097176A1/es unknown
- 2014-07-31 PT PT147560841T patent/PT3028710T/pt unknown
- 2014-07-31 KR KR1020167001591A patent/KR20160036557A/ko active IP Right Grant
- 2014-07-31 US US14/447,853 patent/US9861684B2/en active Active
- 2014-07-31 PL PL14756084T patent/PL3028710T3/pl unknown
- 2014-07-31 PE PE2015002551A patent/PE20160014A1/es unknown
-
2015
- 2015-12-09 CL CL2015003579A patent/CL2015003579A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2016102768A (ru) | 2017-09-06 |
| KR20160036557A (ko) | 2016-04-04 |
| US20150037430A1 (en) | 2015-02-05 |
| ES2527967R1 (es) | 2015-03-09 |
| CA2919314A1 (en) | 2015-02-05 |
| TWI684454B (zh) | 2020-02-11 |
| EP3028710B1 (en) | 2019-09-04 |
| MX2016001238A (es) | 2016-05-24 |
| JP2016528225A (ja) | 2016-09-15 |
| RU2016102768A3 (es) | 2018-05-14 |
| AR097176A1 (es) | 2016-02-24 |
| PL3028710T3 (pl) | 2020-02-28 |
| CN105431155B (zh) | 2020-07-28 |
| JP6466443B2 (ja) | 2019-02-06 |
| TW201536299A (zh) | 2015-10-01 |
| PT3028710T (pt) | 2019-10-31 |
| BR112015031733A2 (pt) | 2017-07-25 |
| CA2919314C (en) | 2023-02-21 |
| US9861684B2 (en) | 2018-01-09 |
| WO2015015037A1 (es) | 2015-02-05 |
| EP3028710A1 (en) | 2016-06-08 |
| ES2527967B1 (es) | 2015-12-28 |
| CL2015003579A1 (es) | 2016-06-10 |
| CN105431155A (zh) | 2016-03-23 |
| ES2755172T3 (es) | 2020-04-21 |
| RU2697249C2 (ru) | 2019-08-13 |
| ES2527967A2 (es) | 2015-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20160014A1 (es) | Formulacion de una composicion sanguinea rica en plaquetas y/o factores de crecimiento, con proteinas gelificadas, y metodo de preparacion de la misma | |
| CO2019006860A2 (es) | Composiciones de silicona rápidamente reticulables a temperaturas ambiente y métodos para fabricarlas y usarlas | |
| BR112018006297A2 (pt) | constructos tubulares absorvíveis | |
| AR095021A1 (es) | Composiciones de azúcares mixtos | |
| CL2017002445A1 (es) | Variantes de pertuzumab y su evaluación. | |
| BR112016022814A8 (pt) | composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico | |
| BR112018068126A2 (pt) | sistemas e métodos para a produção e liberação de pasta fluida gelada medicinal | |
| UY34617A (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas | |
| EP4218411A3 (en) | Stabilization and isolation of extracellular nucleic acids | |
| CL2016002607A1 (es) | Procedimiento para preparar una preparación farmacéutica de acetato de glatiramer y manitol en un contenedor adecuado que comprende las etapas de obtener una solución acuosa de acetato de glatiramer y manitol, filtración de la solución entre 0 y 17,5 grado celsius y llenado del contenedor. pct | |
| BR112017008896A2 (pt) | aparelho e processo para rotular frascos ou ampolas armazenados em temperaturas tão baixas quanto -200°c | |
| BR112016019677A2 (pt) | método de preparação de um condensado celular in vitro, condensado celular, método de preparação de uma estrutura tissular tridimensional e suporte de cultura semelhante a gel | |
| CR20150604A (es) | Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos | |
| CL2017000984A1 (es) | Reducción de la viscosidad de formulaciones farmacéuticas | |
| BR112014031627A2 (pt) | superfícies nanotexturizadas antineblina e artigos contendo os mesmos | |
| AR098704A1 (es) | Producto de confitería congelado con una cubierta de gel fácilmente despegable y un método para la fabricación del mismo | |
| CL2015002835A1 (es) | Nuevos derivados de piridina | |
| CL2015003264A1 (es) | Composición antirregurgitación que mantiene la motilidad intestinal | |
| TR201910056T4 (tr) | Göz sağlığına yönelik bileşim. | |
| AR100608A1 (es) | Complejos de citomegalovirus y usos de los mismos | |
| AR090386A1 (es) | Vacunas de conjugado hidrato de carbono-glicolipido | |
| NZ724923A (en) | Crystalline forms of grapiprant | |
| MX2017008823A (es) | Metodos para aislamiento de plaquetas. | |
| CO2020004407A2 (es) | Formulaciones de espora de nutriente y usos de las mismas | |
| PH12015502556A1 (en) | Modified release formulation |